PeriphaGen
Dr. Douherty is an expert in the mechanisms underlying the development of CIPN especially in regards to the chronic neuropathic pain often associated with CIPN.
This person is not in the org chart
This person is not in any offices
PeriphaGen
PeriphaGen is a biopharmaceutical company focused on peripheral nerve gene therapy and committed to the development of innovative products for difficult-to-treat neurological disorders thereby improving patients' quality of life.